| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | Norepinephrine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] | CTD | PMID:1438304 |
| (R)-noradrenaline | decreases activity | ISO | RGD:734009 | 6480464 | Norepinephrine results in decreased activity of SLC18A2 protein | CTD | PMID:15475732 |
| (R)-noradrenaline | affects binding | ISO | RGD:734009 | 6480464 | Norepinephrine binds to SLC18A2 protein | CTD | PMID:7912402 |
| (S)-amphetamine | affects response to substance | ISO | RGD:11300 | 6480464 | SLC18A2 protein affects the susceptibility to Dextroamphetamine | CTD | PMID:12716422 |
| (S)-amphetamine | affects binding | ISO | RGD:734009 | 6480464 | Dextroamphetamine binds to SLC18A2 protein | CTD | PMID:7912402 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11300 | 6480464 | [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased expression of SLC18A2 protein | CTD | PMID:19653878 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11300 | 6480464 | Estradiol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC18A2 protein]; more ... | CTD | PMID:16011487 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:11300 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 mRNA | CTD | PMID:16011487 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases activity | ISO | RGD:11300 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC18A2 protein | CTD | PMID:16011487 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of SLC18A2 mRNA | CTD | PMID:16079270 |
| 17beta-estradiol | multiple interactions | ISO | RGD:11300 | 6480464 | Estradiol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC18A2 protein]; more ... | CTD | PMID:16011487 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11300 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC18A2 mRNA | CTD | PMID:21889950 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:11300 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC18A2 mRNA | CTD | PMID:20188158 |
| alendronic acid | affects expression | EXP | | 6480464 | Alendronate affects the expression of SLC18A2 mRNA | CTD | PMID:16079270 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC18A2 mRNA | CTD | PMID:16483693 |
| amphetamine | decreases expression | ISO | RGD:11300 | 6480464 | Amphetamine results in decreased expression of SLC18A2 protein | CTD | PMID:11731100 |
| amphetamine | multiple interactions | ISO | RGD:11300 | 6480464 | SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC18A2 protein] | CTD | PMID:11731100 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of SLC18A2 mRNA | CTD | PMID:23123945 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of SLC18A2 mRNA | CTD | PMID:18835401 PMID:18812211 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of SLC18A2 mRNA | CTD | PMID:18812211 PMID:18835401 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of SLC18A2 mRNA | CTD | PMID:17452286 |
| choline | multiple interactions | ISO | RGD:11300 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene | CTD | PMID:20938992 |
| cis-ketoconazole | multiple interactions | ISO | RGD:11300 | 6480464 | Ketoconazole inhibits the reaction [Paraquat results in decreased expression of SLC18A2 protein]; more ... | CTD | PMID:22334051 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of SLC18A2 protein; more ... | CTD | PMID:12007678 |
| cocaine | decreases expression | ISO | RGD:734009 | 6480464 | Cocaine results in decreased expression of SLC18A2 protein | CTD | PMID:12505801 |
| cocaine | affects response to substance | ISO | RGD:11300 | 6480464 | SLC18A2 protein affects the susceptibility to Cocaine | CTD | PMID:12716422 |
| cypermethrin | decreases expression | EXP | | 6480464 | cypermethrin results in decreased expression of SLC18A2 mRNA | CTD | PMID:20815782 |
| DDD | multiple interactions | ISO | RGD:11300 | 6480464 | Dichlorodiphenyldichloroethane inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] | CTD | PMID:18533268 |
| DDT | multiple interactions | ISO | RGD:11300 | 6480464 | DDT inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] | CTD | PMID:18533268 |
| dexamethasone | increases expression | ISO | RGD:734009 | 6480464 | Dexamethasone results in increased expression of SLC18A2 mRNA | CTD | PMID:12782123 |
| diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of SLC18A2 mRNA | CTD | PMID:17452286 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of SLC18A2 mRNA | CTD | PMID:18835401 PMID:18812211 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of SLC18A2 mRNA | CTD | PMID:18812211 PMID:18835401 |
| dieldrin | increases expression | ISO | RGD:11300 | 6480464 | Dieldrin results in increased expression of SLC18A2 protein; more ... | CTD | PMID:16809432 |
| dopamine | multiple interactions | ISO | RGD:734009 | 6480464 | Heptachlor Epoxide inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] | CTD | PMID:10499361 |
| dopamine | multiple interactions | ISO | RGD:11300 | 6480464 | DDT inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:18533268 |
| dopamine | increases uptake | ISO | RGD:11300 | 6480464 | SLC18A2 protein results in increased uptake of Dopamine | CTD | PMID:18533268 |
| dopamine | multiple interactions | EXP | | 6480464 | Dopamine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] | CTD | PMID:1438304 |
| dopamine | decreases activity | ISO | RGD:734009 | 6480464 | Dopamine results in decreased activity of SLC18A2 protein | CTD | PMID:15475732 |
| dopamine | affects binding | ISO | RGD:734009 | 6480464 | Dopamine binds to SLC18A2 protein | CTD | PMID:7912402 |
| dopamine | decreases abundance | EXP | | 6480464 | SLC18A2 results in decreased abundance of Dopamine | CTD | PMID:19409267 |
| estrone | multiple interactions | ISO | RGD:11300 | 6480464 | Estrone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 protein] | CTD | PMID:16011487 |
| folic acid | multiple interactions | ISO | RGD:11300 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene | CTD | PMID:20938992 |
| formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLC18A2 mRNA | CTD | PMID:12679049 |
| GM1 ganglioside | increases expression | EXP | | 6480464 | G(M1) Ganglioside results in increased expression of SLC18A2 mRNA | CTD | PMID:14552908 |
| haloperidol | affects binding | ISO | RGD:734009 | 6480464 | Haloperidol binds to SLC18A2 protein | CTD | PMID:7912402 |
| heptachlor | increases expression | ISO | RGD:11300 | 6480464 | Heptachlor results in increased expression of SLC18A2 protein | CTD | PMID:10499361 PMID:16112329 |
| heptachlor | increases expression | ISO | RGD:11300 | 6480464 | Heptachlor results in increased expression of SLC18A2 protein | CTD | PMID:10499361 more ... |
| heptachlor | increases expression | ISO | RGD:11300 | 6480464 | Heptachlor results in increased expression of SLC18A2 mRNA | CTD | PMID:18577399 |
| heptachlor | increases expression | ISO | RGD:11300 | 6480464 | Heptachlor results in increased expression of SLC18A2 protein | CTD | PMID:16112329 PMID:10499361 |
| histamine | multiple interactions | EXP | | 6480464 | rabeprazole promotes the reaction [SLC18A2 protein results in increased secretion of Histamine] | CTD | PMID:14642791 |
| histamine | affects binding | ISO | RGD:734009 | 6480464 | Histamine binds to SLC18A2 protein | CTD | PMID:7912402 |
| histamine | increases secretion | EXP | | 6480464 | SLC18A2 protein results in increased secretion of Histamine | CTD | PMID:14642791 |
| hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | RGD:734009 | 6480464 | Arbutin results in decreased expression of SLC18A2 mRNA | CTD | PMID:17103032 |
| L-methionine | multiple interactions | ISO | RGD:11300 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene | CTD | PMID:20938992 |
| maneb | multiple interactions | ISO | RGD:11300 | 6480464 | Ketoconazole inhibits the reaction [Maneb results in decreased expression of SLC18A2 protein] | CTD | PMID:22334051 |
| maneb | multiple interactions | ISO | RGD:11300 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA | CTD | PMID:18386188 PMID:20964710 |
| maneb | multiple interactions | ISO | RGD:11300 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA]; more ... | CTD | PMID:20964710 |
| maneb | decreases expression | ISO | RGD:11300 | 6480464 | Maneb results in decreased expression of SLC18A2 protein | CTD | PMID:22334051 |
| manganese atom | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of SLC18A2 mRNA | CTD | PMID:20224926 |
| manganese(0) | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of SLC18A2 mRNA | CTD | PMID:20224926 |
| melatonin | multiple interactions | ISO | RGD:11300 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA] | CTD | PMID:20964710 |
| methamphetamine | decreases expression | ISO | RGD:734009 | 6480464 | Methamphetamine results in decreased expression of SLC18A2 protein | CTD | PMID:16518646 PMID:16622715 |
| methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC18A2 protein | CTD | PMID:17683483 PMID:17686046 |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC18A2 protein | CTD | PMID:17683483 PMID:19326567 |
| methamphetamine | decreases expression | ISO | RGD:734009 | 6480464 | Methamphetamine results in decreased expression of SLC18A2 protein | CTD | PMID:16622715 PMID:16518646 |
| methamphetamine | multiple interactions | EXP | | 6480464 | S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased activity of SLC18A2 protein]; more ... | CTD | PMID:17683483 |
| methamphetamine | increases nitrosation | EXP | | 6480464 | Methamphetamine results in increased nitrosation of SLC18A2 protein | CTD | PMID:17683483 |
| methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC18A2 protein | CTD | PMID:17686046 PMID:17683483 |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC18A2 protein | CTD | PMID:19326567 PMID:17683483 |
| methamphetamine | affects localization | EXP | | 6480464 | Methamphetamine affects the localization of SLC18A2 protein | CTD | PMID:17683483 |
| methamphetamine | decreases response to substance | ISO | RGD:11300 | 6480464 | SLC18A2 protein results in decreased susceptibility to Methamphetamine | CTD | PMID:18643795 |
| methamphetamine | affects response to substance | ISO | RGD:11300 | 6480464 | SLC18A2 protein affects the susceptibility to Methamphetamine | CTD | PMID:12050851 |
| methoxychlor | decreases expression | ISO | RGD:11300 | 6480464 | Methoxychlor results in decreased expression of SLC18A2 protein | CTD | PMID:19459224 |
| methylphenidate | decreases expression | ISO | RGD:11300 | 6480464 | Methylphenidate results in decreased expression of SLC18A2 mRNA | CTD | PMID:22470460 |
| nomifensine | affects binding | ISO | RGD:734009 | 6480464 | Nomifensine binds to SLC18A2 protein | CTD | PMID:7912402 |
| paraquat | decreases expression | ISO | RGD:11300 | 6480464 | Paraquat results in decreased expression of SLC18A2 protein | CTD | PMID:22334051 |
| paraquat | multiple interactions | ISO | RGD:11300 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA | CTD | PMID:18386188 PMID:20964710 |
| paraquat | multiple interactions | ISO | RGD:11300 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA]; more ... | CTD | PMID:20964710 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of SLC18A2 protein; more ... | CTD | PMID:20553223 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in decreased expression of SLC18A2 mRNA]; more ... | CTD | PMID:20553223 |
| paraquat | multiple interactions | ISO | RGD:11300 | 6480464 | Ketoconazole inhibits the reaction [Paraquat results in decreased expression of SLC18A2 protein] | CTD | PMID:22334051 |
| pirinixic acid | multiple interactions | ISO | RGD:11300 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC18A2 mRNA | CTD | PMID:19710929 |
| probenecid | multiple interactions | ISO | RGD:11300 | 6480464 | [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased expression of SLC18A2 protein | CTD | PMID:19653878 |
| rabeprazole sodium | multiple interactions | EXP | | 6480464 | rabeprazole promotes the reaction [SLC18A2 protein results in increased secretion of Histamine] | CTD | PMID:14642791 |
| raloxifene | affects expression | EXP | | 6480464 | Raloxifene affects the expression of SLC18A2 mRNA | CTD | PMID:16079270 |
| reserpine | affects binding | ISO | RGD:734009 | 6480464 | Reserpine binds to SLC18A2 protein | CTD | PMID:7912402 |
| reserpine | multiple interactions | EXP | | 6480464 | Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] | CTD | PMID:9038139 |
| reserpine | affects binding | EXP | | 6480464 | SLC18A2 protein binds to Reserpine | CTD | PMID:9038139 |
| reserpine | increases expression | EXP | | 6480464 | Reserpine results in increased expression of SLC18A2 mRNA | CTD | PMID:8189248 |
| reserpine | affects response to substance | ISO | RGD:11300 | 6480464 | SLC18A2 affects the susceptibility to Reserpine | CTD | PMID:17664021 |
| reserpine | multiple interactions | EXP | | 6480464 | Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] | CTD | PMID:1438304 |
| reserpine | decreases activity | ISO | RGD:734009 | 6480464 | Reserpine results in decreased activity of SLC18A2 protein | CTD | PMID:15475732 |
| reserpine | decreases response to substance | ISO | RGD:734009 | 6480464 | SLC18A2 gene SNP results in decreased susceptibility to Reserpine | CTD | PMID:15475732 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SLC18A2 protein | CTD | PMID:18579341 |
| serotonin | affects binding | ISO | RGD:734009 | 6480464 | Serotonin binds to SLC18A2 protein | CTD | PMID:7912402 |
| serotonin | affects binding | EXP | | 6480464 | SLC18A2 protein binds to Serotonin | CTD | PMID:9038139 |
| serotonin | increases uptake | EXP | | 6480464 | SLC18A2 protein results in increased uptake of Serotonin | CTD | PMID:1438304 |
| serotonin | increases transport | EXP | | 6480464 | SLC18A2 protein results in increased transport of Serotonin | CTD | PMID:9038139 |
| serotonin | multiple interactions | EXP | | 6480464 | Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] | CTD | PMID:9038139 |
| serotonin | multiple interactions | EXP | | 6480464 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin]; more ... | CTD | PMID:1438304 |
| serotonin | affects uptake | ISO | RGD:734009 | 6480464 | SLC18A2 gene SNP affects the uptake of Serotonin | CTD | PMID:15475732 |
| tetrabenazine | affects binding | ISO | RGD:734009 | 6480464 | Tetrabenazine binds to SLC18A2 protein | CTD | PMID:7912402 |
| tetrabenazine | decreases activity | ISO | RGD:11300 | 6480464 | Tetrabenazine results in decreased activity of SLC18A2 protein | CTD | PMID:19616025 |
| tetrabenazine | decreases activity | ISO | RGD:734009 | 6480464 | Tetrabenazine results in decreased activity of SLC18A2 protein | CTD | PMID:15475732 |
| tetrabenazine | multiple interactions | EXP | | 6480464 | Tetrabenazine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] | CTD | PMID:1438304 |
| tributylstannane | multiple interactions | EXP | | 6480464 | tributyltin inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] | CTD | PMID:1438304 |
| vanoxerine dihydrochloride | affects binding | ISO | RGD:734009 | 6480464 | vanoxerine binds to SLC18A2 protein | CTD | PMID:7912402 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in decreased expression of SLC18A2 protein]; more ... | CTD | PMID:20553223 |
| zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of SLC18A2 mRNA; more ... | CTD | PMID:20553223 |